Arcutis Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Arcutis Biotherapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ARQT
Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis.
CEOTodd Franklin Watanabe
CEOTodd Franklin Watanabe
Employees342
Employees342
HeadquartersWestlake Village, California
HeadquartersWestlake Village, California
Founded2016
Founded2016
Employees342
Employees342
ARQT Key Statistics
Market cap3.39B
Market cap3.39B
Price-Earnings ratio-79.94
Price-Earnings ratio-79.94
Dividend yield—
Dividend yield—
Average volume2.10M
Average volume2.10M
High today$28.90
High today$28.90
Low today$27.55
Low today$27.55
Open price$28.54
Open price$28.54
Volume1.15M
Volume1.15M
52 Week high$31.77
52 Week high$31.77
52 Week low$11.13
52 Week low$11.13
Stock Snapshot
Arcutis Biotherapeutics(ARQT) stock is priced at $27.70, giving the company a market capitalization of 3.39B. It carries a P/E multiple of -79.94.
During the trading session on 2025-12-18, Arcutis Biotherapeutics(ARQT) shares reached a daily high of $28.90 and a low of $27.55. At a current price of $27.70, the stock is +0.5% higher than the low and still -4.2% under the high.
Trading volume for Arcutis Biotherapeutics(ARQT) stock has reached 1.15M, versus its average volume of 2.1M.
Over the past 52 weeks, Arcutis Biotherapeutics(ARQT) stock has traded between a high of $31.77 and a low of $11.13.
Over the past 52 weeks, Arcutis Biotherapeutics(ARQT) stock has traded between a high of $31.77 and a low of $11.13.
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own ARQT. This list is generated using Robinhood data, and it’s not a recommendation.